Literature DB >> 18594991

Chronic methamphetamine induces structural changes in frontal cortex neurons and upregulates type I interferons.

Alice Coutinho1, Claudia Flynn, Tricia H Burdo, Ronald F Mervis, Howard S Fox.   

Abstract

While methamphetamine-induced changes in brain neurotransmitters, their receptors, and transporters are well studied, the means by which methamphetamine abuse results in cognitive and behavioral abnormalities is unknown. Here, we administered methamphetamine chronically, in doses relevant to recreational usage patterns, to nonhuman primates. Neurostructural analysis revealed decreased dendritic material and loss of spines in frontal lobe neurons. Molecular examination demonstrated that type I interferons (interferon-alpha and interferon-beta) increased in the frontal lobe in response to chronic methamphetamine treatment, in correlation with the neuronal changes. Chronic methamphetamine thus results in significant changes in the primate brain, inducing cytokines and altering neuronal structure, both of which can contribute to functional abnormalities.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18594991      PMCID: PMC2581635          DOI: 10.1007/s11481-008-9113-7

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  15 in total

1.  Single doses of methamphetamine cause changes in the density of dendritic spines in the prefrontal cortex of gerbils (Meriones unguiculatus).

Authors:  R R Dawirs; G Teuchert-Noodt; M Busse
Journal:  Neuropharmacology       Date:  1991-03       Impact factor: 5.250

2.  Methamphetamine stimulates interferon inducible genes in HIV infected brain.

Authors:  Ian Everall; Shahid Salaria; Eleanor Roberts; Jacques Corbeil; Roman Sasik; Howard Fox; Igor Grant; Eliezer Masliah
Journal:  J Neuroimmunol       Date:  2005-10-24       Impact factor: 3.478

3.  Epidemiology and public health Consequences of methamphetamine use in California's Central Valley.

Authors:  David R Gibson; Martin H Leamon; Neil Flynn
Journal:  J Psychoactive Drugs       Date:  2002 Jul-Sep

4.  Modeling human methamphetamine exposure in nonhuman primates: chronic dosing in the rhesus macaque leads to behavioral and physiological abnormalities.

Authors:  Lisa J Madden; Claudia T Flynn; Michelle A Zandonatti; Meredith May; Loren H Parsons; Simon N Katner; Steven J Henriksen; Howard S Fox
Journal:  Neuropsychopharmacology       Date:  2005-02       Impact factor: 7.853

5.  Striatal dopamine nerve terminal markers in human, chronic methamphetamine users.

Authors:  J M Wilson; K S Kalasinsky; A I Levey; C Bergeron; G Reiber; R M Anthony; G A Schmunk; K Shannak; J W Haycock; S J Kish
Journal:  Nat Med       Date:  1996-06       Impact factor: 53.440

6.  Transgenic expression of IFN-alpha in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration.

Authors:  Y Akwa; D E Hassett; M L Eloranta; K Sandberg; E Masliah; H Powell; J L Whitton; F E Bloom; I L Campbell
Journal:  J Immunol       Date:  1998-11-01       Impact factor: 5.422

7.  Structural abnormalities in the brains of human subjects who use methamphetamine.

Authors:  Paul M Thompson; Kiralee M Hayashi; Sara L Simon; Jennifer A Geaga; Michael S Hong; Yihong Sui; Jessica Y Lee; Arthur W Toga; Walter Ling; Edythe D London
Journal:  J Neurosci       Date:  2004-06-30       Impact factor: 6.167

8.  Long-term methamphetamine administration in the vervet monkey models aspects of a human exposure: brain neurotoxicity and behavioral profiles.

Authors:  William P Melega; Matthew J Jorgensen; Goran Laćan; Baldwin M Way; Jamie Pham; Grenvill Morton; Arthur K Cho; Lynn A Fairbanks
Journal:  Neuropsychopharmacology       Date:  2007-07-11       Impact factor: 7.853

9.  Structural evidence for the neurotoxicity of methylamphetamine in the frontal cortex of gerbils (Meriones unguiculatus): a light and electron microscopical study.

Authors:  U Wahnschaffe; J Esslen
Journal:  Brain Res       Date:  1985-07-01       Impact factor: 3.252

Review 10.  The interferon response circuit: induction and suppression by pathogenic viruses.

Authors:  Otto Haller; Georg Kochs; Friedemann Weber
Journal:  Virology       Date:  2006-01-05       Impact factor: 3.616

View more
  7 in total

Review 1.  Amphetamine toxicities: classical and emerging mechanisms.

Authors:  Bryan K Yamamoto; Anna Moszczynska; Gary A Gudelsky
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

2.  Mechanisms of psychostimulant-induced structural plasticity.

Authors:  Sam A Golden; Scott J Russo
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

Review 3.  Stress- and glucocorticoid-induced priming of neuroinflammatory responses: potential mechanisms of stress-induced vulnerability to drugs of abuse.

Authors:  Matthew G Frank; Linda R Watkins; Steven F Maier
Journal:  Brain Behav Immun       Date:  2011-01-21       Impact factor: 7.217

4.  Social Genomics of Methamphetamine Use, HIV Viral Load, and Social Adversity.

Authors:  Michael J Li; Emily I Richter; Chukwuemeka N Okafor; Mariah M Kalmin; Shareefa Dalvie; Sae Takada; Pamina M Gorbach; Steven J Shoptaw; Steven W Cole
Journal:  Ann Behav Med       Date:  2022-08-30

5.  Methamphetamine-induced behavioral sensitization is enhanced in the HIV-1 transgenic rat.

Authors:  Xiangqian Liu; Linda Chang; Michael Vigorito; Marley Kass; He Li; Sulie L Chang
Journal:  J Neuroimmune Pharmacol       Date:  2009-05-15       Impact factor: 4.147

6.  The danger-associated molecular pattern HMGB1 mediates the neuroinflammatory effects of methamphetamine.

Authors:  Matthew G Frank; Sweta Adhikary; Julia L Sobesky; Michael D Weber; Linda R Watkins; Steven F Maier
Journal:  Brain Behav Immun       Date:  2015-08-04       Impact factor: 7.217

7.  Comparison of brain white matter hyperintensities in methamphetamine and methadone dependent patients and healthy controls.

Authors:  Abdulrasool Alaee; Mehran Zarghami; Samaneh Farnia; Mohammad Khademloo; Talayeh Khoddad
Journal:  Iran J Radiol       Date:  2014-05-15       Impact factor: 0.212

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.